What is the share price of Trident Lifeline Ltd (TLL) today?
The share price of TLL as on 21st September 2026 is ₹369.95. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Trident Lifeline Ltd (TLL) share?
The past returns of Trident Lifeline Ltd (TLL) share are- Past 1 week: 23.30%
- Past 1 month: 32.17%
- Past 3 months: 51.00%
- Past 6 months: 49.72%
- Past 1 year: 30.71%
- Past 3 years: 105.63%
- Past 5 years: 240.82%
What are the peers or stocks similar to Trident Lifeline Ltd (TLL)?
The peers or stocks similar to Trident Lifeline Ltd (TLL) include:What is the market cap of Trident Lifeline Ltd (TLL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Trident Lifeline Ltd (TLL) is ₹440.74 Cr as of 21st September 2026.What is the 52 week high and low of Trident Lifeline Ltd (TLL) share?
The 52-week high of Trident Lifeline Ltd (TLL) is ₹371 and the 52-week low is ₹229.95.What is the PE and PB ratio of Trident Lifeline Ltd (TLL) stock?
The P/E (price-to-earnings) ratio of Trident Lifeline Ltd (TLL) is 23.16. The P/B (price-to-book) ratio is 6.33.Which sector does Trident Lifeline Ltd (TLL) belong to?
Trident Lifeline Ltd (TLL) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Trident Lifeline Ltd (TLL) shares?
You can directly buy Trident Lifeline Ltd (TLL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Trident Lifeline Ltd
TLL Share Price
BSETLL Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
TLL Performance & Key Metrics
TLL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 20.98 | 6.33 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.66 | 5.98 | 0.47% |
TLL Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
TLL Company Profile
Trident Lifeline Ltd produces and sells a wide range of medications, including capsules and syrups, operating in various international markets.
TLL Forecast
TLL Forecasts
TLL
TLL
Income
Balance Sheet
Cash Flow
TLL Income Statement
TLL Income Statement
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 20.59 | 14.30 | 15.99 | 12.39 | 35.88 | 24.96 | 33.01 | 30.34 | 51.58 | 34.29 | ||||||||||
| Operating & Other expenses | 16.77 | 10.66 | 11.40 | 7.75 | 25.48 | 18.44 | 24.48 | 20.62 | 38.97 | 25.20 | ||||||||||
| EBITDA | 3.82 | 3.64 | 4.59 | 4.64 | 10.40 | 6.52 | 8.53 | 9.72 | 12.61 | 9.09 | ||||||||||
| Depreciation/Amortization | 0.39 | 0.54 | 0.16 | 0.61 | 2.74 | 1.46 | 0.91 | 2.46 | 1.23 | 1.62 | ||||||||||
| PBIT | 3.43 | 3.10 | 4.43 | 4.03 | 7.66 | 5.06 | 7.62 | 7.26 | 11.38 | 7.47 | ||||||||||
| Interest & Other Items | 0.37 | 0.49 | 0.50 | 0.55 | 1.55 | 1.13 | 0.99 | 1.24 | 0.77 | 0.86 | ||||||||||
| PBT | 3.06 | 2.61 | 3.93 | 3.48 | 6.11 | 3.93 | 6.63 | 6.02 | 10.61 | 6.61 | ||||||||||
| Taxes & Other Items | 1.04 | 0.32 | 0.83 | 0.69 | -0.95 | 0.87 | 1.68 | 1.71 | 3.89 | 1.58 | ||||||||||
| Net Income | 2.02 | 2.29 | 3.10 | 2.79 | 7.06 | 3.06 | 4.95 | 4.31 | 6.72 | 5.03 | ||||||||||
| EPS | 1.41 | 1.99 | 2.69 | 2.42 | 6.15 | 2.66 | 4.27 | 3.72 | 5.76 | 4.27 |
TLL Company Updates
TLL Stock Peers
TLL Past Performance & Peer Comparison
TLL Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Trident Lifeline Ltd | 23.16 | 6.33 | — |
| Sun Pharmaceutical Industries Ltd | 39.06 | 5.35 | 0.86% |
| Torrent Pharmaceuticals Ltd | 87.38 | 10.75 | 0.68% |
| Zydus Lifesciences Ltd | 22.98 | 3.91 | 0.09% |
TLL Stock Price Comparison
Compare TLL with any stock or ETFTLL Holdings
TLL Shareholdings
TLL Promoter Holdings Trend
TLL Promoter Holdings Trend
TLL Institutional Holdings Trend
TLL Institutional Holdings Trend
In last 3 months, retail holding in the company has increased by 2.41%
In last 3 months, foreign institutional holding of the company has decreased by 1.99%
TLL Shareholding Pattern
TLL Shareholding Pattern
TLL Shareholding History
TLL Shareholding History
smallcases containing TLL stock
smallcases containing TLL stock
Looks like this stock is not in any smallcase yet.
TLL Events
TLL Events
TLL Dividend Trend
TLL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
TLL Dividend Trend
TLL has not given any dividends in last 5 years
TLL Dividends
TLL Dividends
TLL Stock News & Opinions
TLL Stock News & Opinions
Trident Lifeline Limited informed the BSE Limited that it has revised the book closure period for its 13th Annual General Meeting from September 19, 2026, to September 26, 2026, both days inclusive, and the cut-off date for remote e-voting and e-voting during the AGM to Saturday, September 19, 2026, superseding previously announced dates of August 26, 2026.
Trident Lifeline Limited announced the allotment of 24,000 equity shares with a face value of Rs 10 each to Ashish Anandsingh Bafna upon the conversion of an equal number of warrants, receiving Rs 47.88 crore. The company's issued, subscribed, and paid-up equity share capital now stands at Rs 11.957 crore, consisting of 11.957 million equity shares.
Trident Lifeline Limited announced the allotment of 24,000 equity shares with a face value of Rs 10 each to Ashish Anandsingh Bafna upon the conversion of an equal number of warrants, receiving Rs 47.88 crore. The company's issued, subscribed, and paid-up equity share capital now stands at Rs 11.957 crore, consisting of 11.957 million equity shares.
Trident Lifeline Limited announced that its Board of Directors approved the company’s report for the financial year ended March 31, 2026, convened the 13th Annual General Meeting to be held on September 26, 2026, and recommended the reappointment of Mr. Hardik Jigishkumar Desai, who retires by rotation, subject to member approval. The company’s register of members and share transfer books will be closed from September 19, 2026, to September 26, 2026, and appointed CS Mehul Amareliya of M/s. Amareliya & Associates as the scrutinizer for the upcoming Annual General Meeting.
Trident Lifeline Limited informed the BSE Limited that its Board of Directors approved the company’s report for the financial year ended March 31, 2026, convened the 13th Annual General Meeting to be held on September 26, 2026, and recommended the reappointment of Mr. Hardik Jigishkumar Desai, who retires by rotation, subject to member approval. The register of members and share transfer books will remain closed from September 19, 2026, to September 26, 2026, with a cut-off date for remote e-voting on September 18, 2026, and appointed CS Mehul Amareliya of M/s. Amareliya & Associates as the scrutinizer for the AGM.
Net profit of Trident Lifeline rose 64.38% to Rs 5.03 crore in the quarter ended June 2026 as against Rs 3.06 crore during the previous quarter ended June 2025. Sales rose 42.82% to Rs 33.72 crore in the quarter ended June 2026 as against Rs 23.61 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales33.7223.61 43 OPM %25.2721.90 - PBDT8.235.39 53 PBT6.613.93 68 NP5.033.06 64 Powered by Capital Market - Live
Trident Lifeline will hold a meeting of the Board of Directors of the Company on 29 July 2026.
Trident Lifeline will hold a meeting of the Board of Directors of the Company on 5 May 2026.
Net profit of Trident Lifeline rose 54.12% to Rs 4.30 crore in the quarter ended December 2025 as against Rs 2.79 crore during the previous quarter ended December 2024. Sales rose 117.33% to Rs 25.71 crore in the quarter ended December 2025 as against Rs 11.83 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales25.7111.83 117 OPM %19.8034.49 - PBDT8.484.08 108 PBT6.023.48 73 NP4.302.79 54 Powered by Capital Market - Live
Trident Lifeline will hold a meeting of the Board of Directors of the Company on 17 January 2026.Powered by Capital Market - Live
In last 6 months, promoter holding in the company has decreased by 1.52%
Pledged promoter holdings is insignificant